Asia-Pacific's Growing Role in Global Clinical Trials
Author: Sara Gambrill
Volume discounts and licensing opportunities are available. For information, please call (866) 219-3440, ext 4 or email
sales@centerwatch.com
CenterWatch is excited to introduce Asia-Pacific’s
Growing Role in Global Clinical Trials. The Asia-Pacific is becoming an integral part
of global drug development, and in the future will take a leadership position on some global
projects. CenterWatch created Asia-Pacific’s
Growing Role in Global Clinical Trials to provide you with in-depth information on the
future of this region and how you can be a part of it.
Topics Include:
- Regulatory and business landscape
- Market intelligence
- Drug and device pipeline in 2007
- Charts and figures
- Directory of CRO companies
- Size and growth for the following markets:
- Australia
- China
- India
- Japan
- South Korea
Recommended for:
- Biotech and pharmaceutical companies planning to enter the Asia-Pacific market
- Investment firms covering the life sciences industry in emerging markets
- CROs conducting business in Asia-Pacific countries
Learn what global biopharmaceutical executives and the heads of contract research
organizations who have on-the-ground experience in the region say about the
Asia-Pacific region.